Navigation Links
Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2013 Financial Results
Date:8/1/2013

SAN DIEGO, Aug. 1, 2013 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today provided a corporate update and reported financial results for the second quarter ended June 30, 2013.

"We are very encouraged by the positive response from patients and physicians since BELVIQ became available in US pharmacies on June 11," said Jack Lief, Arena's President and Chief Executive Officer. "While it is still early in the launch, the progress made to date reinforces the significant opportunity we see for BELVIQ in the medical management of overweight and obese patients."

Recent Developments:BELVIQ US Launch

  • In June 2013, Eisai launched BELVIQ in the United States.
  • Approximately 12,500 BELVIQ prescriptions have been filled between the availability of BELVIQ in US pharmacies on June 11 and July 19, 2013, according to IMS Health.
  • In the second quarter of 2013, Arena recognized $1.3 million in net product sales, which is 31.5% of Eisai's net product sales of BELVIQ. Arena and Eisai currently recognize revenue of BELVIQ net product sales when Eisai ships product to its wholesalers.
  • Received $65 million in milestone payments from Eisai in connection with the US launch.
  • BELVIQ Rest of World

  • In July 2013, Arena's wholly owned subsidiary, Arena Pharmaceuticals GmbH, and CY Biotech Company Ltd. (CYB) entered into a marketing and supply agreement for BELVIQ in Taiwan. Under the agreement, Arena granted CYB the rights to market and distribute BELVIQ in the territory for weight loss or weight management in obese and overweight patients, subject to regulatory approval of BELVIQ by the Taiwan Food and Drug Administration. Arena received a net upfront payment of $2 million from CYB.
  • Received a $0.5 million milestone payment from Eisai in connection with Eisai Limited's June 2013 New Drug Submission for the marketing
    '/>"/>

  • SOURCE Arena Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, August 1
    2. Arena Pharmaceuticals to Present at the 2013 Wells Fargo Securities Healthcare Conference
    3. Former Semi-Pro Arena Football Player Bridged to Heart Transplant with the SynCardia Total Artificial Heart
    4. Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
    5. BIOCOM Applauds Arena Pharmaceuticals Commitment to Innovation, Contributions to Southern California Life Science Community
    6. Carena Launches 24/7 Virtual Care Delivery Service for Hospital Systems and Primary Care Clinics
    7. Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2013 Financial Results
    8. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, May 2
    9. Arena Pharmaceuticals Initiates Phase 1 Clinical Trial of APD334 for Autoimmune Diseases
    10. Arena Pharmaceuticals Provides Corporate Update and Reviews Fourth Quarter and Full Year 2012 Financial Results
    11. Arena Pharmaceuticals to Present at the Cowen and Company 33rd Annual Health Care Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/5/2015)... Calif. , May 5, 2015 ... biopharmaceutical company focused on cardio-renal, gastrointestinal, and metabolic ... clinical trial evaluating tenapanor in Stage 3 chronic ... and albuminuria did not meet the primary endpoint ... patients compared to patients receiving placebo. ...
    (Date:5/5/2015)... , May 5, 2015 North ... $94.9 million in 2014, and is estimated to grow ... 7.8% from 2014 to 2019. Browse through ... Market for an analysis of industry trends and segments, ... http://www.micromarketmonitor.com/market/north-america-glaucoma-surgery-devices-8830146604.html Early buyers ...
    (Date:5/5/2015)... Valley Medical Center, named a Top 100 Hospitals® in the ... to deploy the wireless Leaf Patient Monitoring System in its ... labor and risk of caesarian births. Studies show ... is reduced in mothers who are upright and mobile during ... epidurals and tend to lie in their labor room beds. ...
    Breaking Medicine Technology:Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 2Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 3Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 4Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 5Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 6North America Ophthalmology Glaucoma Surgery Device Market is Expected to Reach $138.3 Million by 2019, at a CAGR of 7.8% From 2014 to 2019 2North America Ophthalmology Glaucoma Surgery Device Market is Expected to Reach $138.3 Million by 2019, at a CAGR of 7.8% From 2014 to 2019 3Desert Valley Medical Center First to Use Leaf Patient-Wearable Technology to Help Reduce C-Sections, Speed Labor 2Desert Valley Medical Center First to Use Leaf Patient-Wearable Technology to Help Reduce C-Sections, Speed Labor 3Desert Valley Medical Center First to Use Leaf Patient-Wearable Technology to Help Reduce C-Sections, Speed Labor 4
    ... , RYE, N.Y. , July 28 Curemark, ... on the treatment of neurological diseases, announced that Saint Peter,s University Hospital ... Phase III clinical trials for CM-AT , Curemark,s autism treatment.   ... Saint Peter,s is affiliated ...
    ... SEATTLE , July 28 HemaQuest Pharmaceuticals, ... for sickle cell disease, beta thalassemia and EBV-related cancers, ... to its Series B financing by new investor, ... B financing to $16M . The financing is ...
    Cached Medicine Technology:Curemark Opens Autism Trials at New Jersey Site 2Curemark Opens Autism Trials at New Jersey Site 3HemaQuest Pharmaceuticals Raises Additional $4M to Bring Total to $16M in Series B Financing 2
    (Date:5/5/2015)... May 05, 2015 Leveraging the industry-leading ... in Greece, an experienced team of fertility specialists are ... for patients around the globe. , “We’re honored that ... unquestionably remains a global leader in reproductive medicine. The ... fertility specialists in the world who play an important ...
    (Date:5/5/2015)... (PRWEB) May 05, 2015 From ... the established leader in enabling enterprise collaboration ... to help customers speed up and simplify the ... technologies, AvePoint Solutions for Office 365 ... faster while ensuring sustainable user adoption and effectively ...
    (Date:5/5/2015)... Patricia George knows all too well the debilitating effects ... specialist at the University of Pittsburgh Medical Center (UPMC), ... idea entered her mind for Team PHenomenal Hope. ... 2010 PHA International Conference,” George recalled. “The speakers – ... climb up Mt. Kilimanjaro and I remember thinking how ...
    (Date:5/5/2015)... (PRWEB) May 05, 2015 This year, ... Medals, four Special Merit Awards, three Gold Medals and ... projects are described as follows: , (1) Grand Prize ... Robotic Mannequin for Fashion Design and Fitting, Principal Investigator: ... , The apparel industry relies very much on the ...
    (Date:5/5/2015)... Freeport, Grand Bahama (PRWEB) May 05, 2015 ... published its Orthopedic Lifestyle Report today. The study was ... orthopedic conditions such as osteoarthritis and sports-related ... chronic pain and stiffness was the most prevalent symptom ... reduced functionality such as walking, standing and bending over. ...
    Breaking Medicine News(10 mins):Health News:Maternity Health IVF Clinic in Greece Demonstrates Industry-Leading Fertility Technology 2Health News:Maternity Health IVF Clinic in Greece Demonstrates Industry-Leading Fertility Technology 3Health News:AvePoint Unveils New Solutions for Microsoft Office 365 & Azure at Microsoft Ignite 2015 2Health News:AvePoint Unveils New Solutions for Microsoft Office 365 & Azure at Microsoft Ignite 2015 3Health News:World PH Day: Team PHenomenal Hope Races to Spread the Word about Pulmonary Hypertension 2Health News:PolyU wins top prizes in Geneva’s Invention Expo 2Health News:PolyU wins top prizes in Geneva’s Invention Expo 3Health News:PolyU wins top prizes in Geneva’s Invention Expo 4Health News:PolyU wins top prizes in Geneva’s Invention Expo 5Health News:Okyanos Study Finds Orthopedic Patients Plagued with Pain 2Health News:Okyanos Study Finds Orthopedic Patients Plagued with Pain 3
    ... from the ceremony long used to initiate Jewish boys ... parents decided to move away from the tradition of ... the foreskin from the penis. ,There was no crying, ... traditionally performs ritual circumcisions in the Jewish faith.,``I knew before ...
    ... discovered an association between foie gras prepared from goose ... in rheumatoid arthritis or tuberculosis. ,Dr. Alan Solomon, ... School of Medicine in Knoxville, says that the new ... that a food product can hasten amyloid development. ...
    ... A 111-year-old Japanese engineer born at the end of the ... world's newest oldest man, and joked he was sorry for ... said that avoiding alcohol was a secret of his ... World Records by the mayor of his local municipality. ...
    ... a ban on the use of plastic and polythene materials ... day before flooded Guwahati, throwing the city out of ... ban the use of plastic and polythene is one of ... would be enforced very strictly and there would be penalties ...
    ... a scientific study has backed them up by showing that ... than they really are. Researchers at the University of Alberta ... of Victoria, carried out the study. ,As a ... nearly 700 adolescents between 12 to 19 years of age ...
    ... who recently starred in 'Ocean's 13' did not scold ... of marijuana because she used to smoke it ... to ignore the incident even though she knew he ... ,She says: 'I used to smoke with my ...
    Cached Medicine News:Health News:The Custom of Circumcision Decline in the US 2Health News:Scientists Establish Link Between Foie Gras and Disease 2Health News:Dating, Drugs and Sex Make Teens Feel Older Than They are 2
    ... The Techne TC-312 Thermal Cycler is ... market. Features & Benefits include: ... networking, Alpha-numeric screen, keypad and program naming, ... numerous applications in Molecular Biology and Diagnostic ...
    PTC-100 cycler with Hot Bonnet heated lid,holds sixty 0.5ml tubes...
    ... 0.2ml sub-ambient block and automatic height adjusting ... up to 3C/second; Accurate block performance; Absolute ... than 0.5C within 15 seconds; Oil free ... storage of up to 60 programs; 0.2 ...
    ... The RapidCycler is the first instrument ... reactions. The instrument's rapid temperature cycling system ... air to samples contained in microcapillary tubes ... cooling the samples with blasts of high ...
    Medicine Products: